Skip to content

SankoreAfrican research intelligence

Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Yohannes Hailemichael · Sankore

Yohannes Hailemichael

ORCID, self-asserted

ORCID 0000-0002-4831-6077

This profile carries an ORCID the researcher published on their own record — the strongest evidence available short of a human confirming it.

Publications

14

Citations

73

h-index

5

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

3

Publications

4 works in the graph, newest first.

The role of economic factors in shaping and constituting the household burden of neglected tropical diseases of the skin: Qualitative findings from Ghana and Ethiopia
2024Social Science & MedicineJournalOpen accessFirst author16 citations10.1016/j.socscimed.2024.117094
Buruli-RifDACC: Evaluation of the efficacy and cost-effectiveness of high-dose versus standard-dose rifampicin on outcomes in Mycobacterium ulcerans disease, a protocol for a randomised controlled trial in Ghana
2023NIHR Open ResearchJournalOpen access2 citations10.3310/nihropenres.13332.2
Additional files for BuruliRifDACC
2022Zenodo (CERN European Organization for Nuclear Research)JournalOpen access6 citations10.5281/zenodo.7263509
Buruli-RifDACC: Evaluation of the efficacy and cost-effectiveness of high-dose versus standard-dose rifampicin on outcomes in Mycobacterium ulcerans disease, a protocol for a randomised controlled trial in Ghana
2022NIHR Open ResearchJournalOpen access3 citations10.3310/nihropenres.13332.1